Skip to main content
Premium Trial:

Request an Annual Quote

Charles Harwood, Tim Derrington, John Sluis, John Fazio

BioReliance has named Charles Harwood, who currently is executive chairman, to the post of interim CEO in the wake of the departure of former CEO Tim Derrington.
 
BioReliance, which Invitrogen sold in April to Avista Capital Partners for $210 million, noted that since June three senior executives have joined the company, including David Onions as CSO, David Walker as CFO, and Darryl Goss as VP of Global Process Excellence.
 
Harwood formerly was president and CEO of Focus Diagnostics and was SVP of venture development at Covance.
 

 
Cepheid CFO John Sluis will retire on Dec. 31, the company said in its quarterly earnings statement this week. The company is seeking a replacement for Sluis, who will remain a consultant for Cepheid through 2008. Sluis joined Cepheid as VP of finance and CFO.
 

 

Sequenom has appointed John Fazio to its board of directors. Fazio, who also will serve as chairman of the firm’s audit committee, formerly was senior general practice partner at PricewaterhouseCoopers, where he had a 35-year career.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.